Grace

growth-positive

Grace, co-founded by Tom Livne, aims to repurpose abandoned drugs using AI technology. The company is preparing to raise its first funding round, targeting $10–20 million from local and international investors. Livne, known for founding Verbit, has invested hundreds of thousands of dollars of his own money into Grace. His partners in the venture are Shay Liraz and David Futorian, both graduates of the elite Talpiot program. Graces AI-powered software will analyze data from discontinued drugs to identify new development possibilities. The company is in the clinical trial stage and is expected to leverage AI technology for drug discovery.